| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/16/1995 | CA1335573C Dispersible tablets of dihydroergotoxine and of acid addition salts thereof |
| 05/13/1995 | CA2134192A1 5, 6-bicyclic glycoprotein iib/iiia antagonists |
| 05/11/1995 | WO1995012612A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase |
| 05/11/1995 | WO1995012611A1 Endothelin receptor antagonists |
| 05/11/1995 | WO1995012594A1 7H-IMIDAZO(1,2-a)PYRAZINE-8-ONE NMDA RECEPTOR ANTAGONISTS |
| 05/11/1995 | WO1995012592A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments |
| 05/11/1995 | WO1995012591A1 Phenylindole compounds |
| 05/11/1995 | WO1995012587A1 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 05/11/1995 | WO1995012584A1 Novel benzoyl guanidines, their production and their use in medicaments |
| 05/11/1995 | WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications |
| 05/11/1995 | WO1995012578A1 Short-acting dihydropyridines |
| 05/11/1995 | WO1995012576A1 New cyclopropyl derivatives, preparation method thereof and applications |
| 05/11/1995 | WO1995012572A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase |
| 05/11/1995 | WO1995012417A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists |
| 05/11/1995 | WO1995012415A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 05/11/1995 | WO1995012412A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 05/11/1995 | WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 05/11/1995 | WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | WO1995007697A3 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 05/11/1995 | CA2175902A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 05/11/1995 | CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | CA2175838A1 Novel benzoyl guanidines, their production and their use in medicaments |
| 05/11/1995 | CA2175837A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments |
| 05/11/1995 | CA2175795A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists |
| 05/11/1995 | CA2175685A1 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 05/11/1995 | CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 05/11/1995 | CA2175214A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 05/11/1995 | CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 05/11/1995 | CA2173875A1 Endothelin receptor antagonists |
| 05/11/1995 | CA2170766A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase |
| 05/11/1995 | CA2152822A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase |
| 05/10/1995 | EP0652285A2 Lactic acid bacteria and fermented milk product |
| 05/10/1995 | EP0652217A1 N-substituted imidazole derivatives |
| 05/10/1995 | EP0652214A1 N-Aryl-2-cyano-3-hydroxy propenamide derivatives, a method for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 05/10/1995 | EP0652006A1 Use of 2-phenyl-3-aryl-dihychobenzopyrans for lowering serum cholesterol |
| 05/10/1995 | EP0652003A1 Methods for inhibiting smooth muscle cell proliferation and restinosis |
| 05/10/1995 | EP0652000A1 Methods for inhibiting angiogenisis and angiogenic diseases |
| 05/10/1995 | EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 05/10/1995 | EP0651654A1 Lysozyme dimer and compositions containing the same |
| 05/10/1995 | EP0651645A1 Medicament for inhibiting neutrophil elastase and cathepsin g |
| 05/10/1995 | CN1102527A Piperazinocarbonylcarbostyrils as peripheral vasodilators |
| 05/10/1995 | CN1028361C Glutaric acid derivatives and preparations thereof |
| 05/09/1995 | US5414012 Indalyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents |
| 05/09/1995 | US5414003 Pyridinylmethyl-substituted pyridines and pyridones |
| 05/09/1995 | US5413998 Benzo-fused thiazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/09/1995 | US5413997 Triphenylmethane derivatives |
| 05/09/1995 | CA2134251A1 N-substituted imidazole derivatives |
| 05/09/1995 | CA1335504C Substituted 3,4-dihydro-2h-benzopyrans, process for their preparation, their use and pharmaceutical products based on these compounds |
| 05/06/1995 | CA2134827A1 Methods for lowering serum cholesterol |
| 05/05/1995 | CA2135044A1 N-aryl-2-cyano-3-hydroxypropenamides derivatives, proc ess for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 05/04/1995 | WO1995011908A1 Novel phosphorus-containing spin-trap compositions |
| 05/04/1995 | WO1995011904A1 Novel a1 adenosine receptor agonists and antiagonists |
| 05/04/1995 | WO1995011900A1 Process for the preparation of substituted thiopyran-1-oxides |
| 05/04/1995 | WO1995011891A1 Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes |
| 05/04/1995 | WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
| 05/04/1995 | WO1995011687A1 Therapeutic use of cis-element decoys in vivo |
| 05/04/1995 | WO1994028132A3 Opioid receptors: compositions and methods |
| 05/04/1995 | CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
| 05/04/1995 | CA2152363A1 Novel phosphorus-containing spin-trap compositions |
| 05/03/1995 | EP0650961A1 Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments |
| 05/03/1995 | EP0650493A1 Hybrid oligonucleotide phosphorothioates |
| 05/03/1995 | EP0650484A1 Endothelin receptor antagonists |
| 05/03/1995 | EP0650368A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 05/03/1995 | EP0406398B1 Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 05/03/1995 | CA2134866A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 05/02/1995 | US5412104 Hypotensive and antiviral agents |
| 05/02/1995 | US5412101 Sulphorous derivatives of imidazole, and their use as medicaments and the pharmaceutical compositions containing them |
| 05/02/1995 | US5412095 Terazosin monohydrochloride and processes and intermediate for its production |
| 05/02/1995 | US5411989 Nitric acid esters of cyclohexanol derivatives |
| 05/02/1995 | US5411975 Thiazolidinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411962 Benzomorpholinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents |
| 05/02/1995 | US5411961 Benzo-fused morpholinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411959 1,4-Thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411958 Benzothiomorpholinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents |
| 05/02/1995 | US5411957 3-azabicyclo[3.2.1]-nonanyl-terminated non-piptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents |
| 05/02/1995 | US5411956 Lipolytic enzyme inhibitors |
| 05/02/1995 | US5411954 Benzo-fused oxazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411953 Oxazopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | US5411950 Benzo-fused oxazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/02/1995 | CA1335452C Substituted tetralins, chromans and related compounds in the treatment of asthma |
| 05/02/1995 | CA1335451C Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
| 05/02/1995 | CA1335450C Indole and indazole keto sulphones as leukotriene antagonists |
| 04/29/1995 | CA2134418A1 Linear adhesion inhibitors |
| 04/27/1995 | WO1995011259A1 Platelet-derived growth factor analogues |
| 04/27/1995 | WO1995011244A1 Pyridazino quinoline compounds |
| 04/27/1995 | WO1995011240A1 Amine derivatives as calcium channel antagonists |
| 04/27/1995 | WO1995011238A1 Heterocyclic amines for treating ischaemic strokes |
| 04/27/1995 | WO1995011231A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995011221A1 Calcium receptor-active arylalkyl amines |
| 04/27/1995 | WO1995011021A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents |
| 04/27/1995 | WO1995011016A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 04/27/1995 | WO1995011014A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995011013A2 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 04/27/1995 | DE4336051A1 1,2-Dihydro-2-oxopyridines |
| 04/27/1995 | DE3448490C2 Verwendung von Pteridinderivaten zur Behandlung von Herzarrhythmien The use of pteridine derivatives for the treatment of cardiac arrhythmias |
| 04/27/1995 | CA2173468A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2171332A1 Pyridazino quinoline compounds |
| 04/27/1995 | CA2170735A1 Amidino derivatives useful as nitric oxide synthase inhibitors |